FMP
NASDAQ
0.473 USD
-0.0076 (-1.61%)
Mr. Harry Simeonidis
Healthcare
Medical - Devices
https://gbs.inc
NASDAQ
GBS Inc. operates as a biosensor diagnostic technology company in the Asia-Pacific and North America. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. GBS Inc. has a research agreement with Johns Hopkins Bloomberg School of Public Health for the development of saliva-based diagnostic tests. The company was formerly known as Glucose Biosensor Systems (...
0001725430
US36151G1058
N/A
708 3rd Avenue
646 828 8258
US
12
Dec 23, 2020
0001725430
NASDAQ
Medical - Devices
Healthcare
-
US36151G1058
US
0.47
0
51.58k
433.58k
-
0.36-2.89
0
-
-
-
-
-0.94
-
https://gbs.inc
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.